Chondroitin sulphate inhibits connective tissue mast cells

British Journal of Pharmacology

Volumn 131, Issue 6, 2000, Pages 1039-1049

  Theoharides, T C ^a   Patra, P ^a   Boucher, W ^a   Letourneau, R ^a   Kempuraj, D ^a   Chiang, G ^a   Jeudy, S ^a   Hesse, Leah ^a   Athanasiou, A ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Chondroitin sulphate; Disodium cromoglycate; Heparin; Histamine; Mast cells; Proteoglycans; Secretion

Indexed keywords

CALCIUM ION; CHONDROITIN SULFATE; CROMOGLYCATE DISODIUM; HISTAMINE; HISTAMINE RELEASE INHIBITOR; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYSACCHARIDE;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; BONE MARROW; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONNECTIVE TISSUE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HISTAMINE RELEASE; IMAGE ANALYSIS; MAST CELL DEGRANULATION; MAST CELL LEUKEMIA; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT; SECRETORY GRANULE; TACHYPHYLAXIS; UMBILICAL CORD;

EID: 0033696744     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703672     Document Type: Article

References (120)

1. Protective effect of heparin on immunologically induced tracheal smooth muscle contraction in vitro
2. Effects of inhaled heparin on immunologic and non-immunologic bronchoconstrictor responses in sheep
3. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin
4. Inhibition of antigen-induced airway and cutaneous responses by heparin: A pharmacodynamic study
5. 3-mediated mast cell degranulation
6. Comparison of the histamine-releasing action of substance P on mast cells and basophils from different species and tissues
7. The Ca signal from fura-2 loaded mast cells depends strongly on the method of dye-loading
8. Inhibitory effects of low molecular weight heparin on mediator release by mast cells:preferential inhibition of cytokine production and mast cell dependent cutaneous inflammation
9. Inflammatory mediators and asthma
10. The histologic and functional characterization of enzymatically dispersed intestinal mast cells of nonhuman primates: Effects of secretagogues and antiallergic drugs on histamine secretion
11. Differences in requirements and actions of various histamine-releasing agents
12. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli
13. Inhibition of tumour necrosis factor-alpha (TNF-α) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium
14. Potentiation of tumor necrosis factor-alpha-mediated cytotoxicity of mast cells by their production of nitric oxide
15. Stem cell factor-dependent human cord blood derived mast cells express alpha-and beta-tryptase, heparin and chondroitin sulphate
16. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects
17. Heterogeneity of human mast cells based on cytokine content
18. Chondroitin sulfate as a regulator of neuronal patterning in the retina
19. Reactive oxygen species generation and histamine release by activated mast cells:modulation by nitric oxide synthase inhibition
20. 3H-N-acetyl glucosamine in the intestinal mucosa of patients with inflammatory bowel disease
21. Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels
22. Mast cells, neuropeptides and inflammation
23. Characterization of histamine secretion from mechanically dispersed human lung mast cells: Effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides
24. Inhibitory effect of neuraminidase on SP-induced histamine release and TNF-α mRNA in rat mast cells. Evidence of a receptor-independent mechanism
25. Comparison of circulating and peritoneal leukocyte cationic proteins in release of histamine from rat mast cells
26. 3H] serotonin release
27. Purification of rat peritoneal mast cells: Occupation of IgE receptors by IgE prevents loss of the receptors
28. Articular mastocytosis in rheumatoid arthritis
29. 1
30. Inhibitory effect of heparin upon histamine release by trypsin, antigen and proteose
31. Effect of nedocromil sodium on the compound exocytosis of mast cells
32. Release of histamine by substance P. Naunyn-Sehmiedebergs
33. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat
34. Effect of flavone inhibitors of transport ATPases on histamine secretion from rat mast cells
35. 1-antagonist derived anti-allergic drugs: Relation to lipophilicity and membrane effects
36. Neuropeptides and the pathogenesis of allergy
37. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme
38. Comparison of human lung and intestinal mast cells
39. Differential release of mast cell interleukin-6 via c-kit
40. New concepts about the mast cell
41. Neuropeptide regulation of the expression of immediate hypersensitivity
42. Mast cells as a source of multifunctional cytokines
43. No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis
44. Structure and biosynthesis of proteoglycans
45. Inhibition of immunoglobulin but not polypeptide basestimulated release of histamine and arachidonic acid by anti-inflammatory steroids
46. Recent developments in monitoring calcium and protein interactions in cells using fluorescence lifetime microscopy
47. Heparin inhibits inositol-trisphosphate-induced calcium release from permeabilized rat liver cells
48. Heparin is essential for the storage of specific granule proteases in mast cells
49. A deficit of chondroitin sulfate proteoglycans on the bladder urothelium in interstitial cystitis
50. CD48 binds to heparin sulfate on the surface of epithelial cells
51. Cell cycle-associated changes in receptors for IgE during growth and differentiation of a rat basophilic leukemia cell line
52. New anti-allergy drugs - The lodoxamides
53. Intracellular ionized calcium
54. An essential heparin-binding domain in the fibroblast growth factor receptor kinase
55. Characterization of mast cell-committed progenitors present in human umbilical cord blood
56. + cord blood cells
57. Heparin inhibits the inositol 1, 4, 5-trisphosphate-dependent, but not the independent, calcium release induced by guanine nucleotide in vascular smooth muscle
58. Continuous release of secretory granule proteoglycans from a strain derived from the bone marrow of a patient with diffuse cutaneous mastocytosis
59. Il-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III and IL-3
60. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide
61. Heparin binding, internalization, and metabolism in vascular smooth muscle cells: I. Upregulation of heparin binding correlates with antiproliferative activity
62. Heparin binding, internalization, and metabolism in vascular smooth muscle cells: II. Degradation and secretion in sensitive and resistant cells
63. 2 in rat peritoneal mast cells activated with peptides
64. Nonrespitory functions of pulmonary cells: The mast cell
65. Differential regulation of mast cell function by IL-10 and stem cell factor
66. Glycosaminoglycans and their binding to biological macromolecules
67. Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells
68. Human mast cell heterogeneity: Histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli
69. Immunologic mast cell mediated responses and histamine release are attenuated by heparin
70. The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production
71. Modulation of rat serosal mast cell biochemistry by in vivo dexamethasone administration
72. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells
73. Inhibitory effects of sialic acid- or N-Acetylglucosamine-specific lectins on histamine release induced by compound 48/80, bradykinin and a polyethylenimine in rat peritoneal mast cells
74. Glucosamine and chondroitin for treatment of osteoarthritis. A systematic quality assessment and meta-analysis
75. Biochemical and functional characterization of proteoglycans isolated from basophils of patients with chronic myelogenous leukemia
76. The role of mast cells in atherosclerosis
77. 2+ images obtained by optical sectioning of fura-2 loaded mast cells
78. Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80
79. Activation of rat peritoneal mast cells by substance P and mastoparan
80. Heparin oligosaccharides bind L and P-selectin and inhibit acute inflammation
81. Potassium-induced histamine release from mast cells and its inhibition by ketotifen
82. Development regulation of neural response to FGF-1 and FGF-2 by heparin sulfate proteoglycan
83. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine
84. Sulfated glycosaminoglycans of guinea pig basophilic leukocytes
85. The effect of disodium cromoglycate on the release of histamine and degranulation of rat mast cells induced by compound 48/80
86. Mucosal mast cells. II: Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells
87. Regulation of calcium influx by second messengers in rat mast cells
88. On the actions of substance P, somatostatin and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin
89. Phenotypic expression of proteoglycan in mast cells of the human nasal mucosa
90. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, betahexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells
91. Release of highly-sulphated glycosaminoglycans and histamine from human basophils
92. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids
93. Differential effect of histamine-3 receptor active agents on brain but not peritoneal mast cell activation
94. Uptake of chondroitin sulfate by mammalian cells in tissue culture
95. Uptake of chondroitin sulfate by mammalian cells in culture. II. Kinetics of uptake and autoradiography
96. Uptake of chondroitin sulfate by mammalian cells in culture. III. Effect of incubation media, metabolic inhibitors and structural analogs
97. Intracellular measurement of calcium using fluorescent probes
98. Mediators of human mast cells and human mast cell subsets
99. Homology of the rat basophilic leukemia cell and the rat mucosal mast cell
100. Purification and characterization of proteaseresistant secretory granule proteoglycans containing chondroitin sulfate di-B and heparin-like glycosaminoglycans from rat basophilic leukemia cells
101. Mast cell heterogeneity: Effects of neuroenteric peptides on histamine release
102. Urinary glycosaminoglycan levels are increased in acute severe asthma-a role for eosinophil-derived gelatinase B?
103. Aching for an arthritis cure
104. Cellular interactions between the immune and peripheral nervous system. A normal role for mast cells?
105. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs
106. Mast cells: The immune gate to the brain
107. Mast cell: A neuroimmunoendocrine master player
108. Somatostatin induces histamine secretion from rat peritoneal mast cells
109. Differential release of serotonin and histamine from mast cells
110. Sulphated polysaccharides inhibit mast cell (MC) secretion and may be useful in bone inflammation
111. Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell
112. Interstitial cystitis: A neuroimmunoendocrine disorder
113. Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein
114. Quercetin-induced expression of rat mast cell protease II and accumulation of secretory granules in rat basophilic leukemia cells
115. 2 in rat peritoneal mast cells; roles of cytosolic calcium and protein tyrosine kinases
116. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses
117. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1
118. The mast cell and synovial inflammation
119. Terminal ileal mucosal mast cells in irritable bowel syndrome
120. Mast-cell heparin demystified